Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

543 ARTÍCULOS , VIENDO DEL 241 AL 255

Potential of astrocytes in targeting therapy for Alzheimer's disease

Bi W, Lei T, Cai S, Zhang X, Yang Y, Xiao Z, Wang L, Du H.

Int Immunopharmacol. 2022 Dec;113(Pt A):109368. doi: 10.1016/j.intimp.2022.109368. Epub 2022 Oct 29.

ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies

Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC.

Mol Neurodegener. 2022 Nov 8;17(1):72. doi: 10.1186/s13024-022-00574-4.

Marine Sources of DHA-Rich Phospholipids with Anti-Alzheimer Effect

Ferreira I, Rauter AP, Bandarra NM.

Mar Drugs. 2022 Oct 25;20(11):662. doi: 10.3390/md20110662.

Hope on the horizon for Alzheimer's disease treatment?

The Lancet Healthy Longevity.

Lancet Healthy Longev. 2022 Nov;3(11):e722. doi: 10.1016/S2666-7568(22)00251-3.

Astrocytes as a Therapeutic Target in Alzheimer's Disease-Comprehensive Review and Recent Developments

Rodríguez-Giraldo M, González-Reyes RE, Ramírez-Guerrero S, Bonilla-Trilleras CE, Guardo-Maya S, Nava-Mesa MO.

Int J Mol Sci. 2022 Nov 7;23(21):13630. doi: 10.3390/ijms232113630.

Exploring New Vista for Alzheimer's Disease Drug Targets

Kumar D.

Curr Top Med Chem. 2022;22(22):1847-1848. doi: 10.2174/156802662222221007161622.

Tau immunotherapy in Alzheimer's disease and progressive supranuclear palsy

Karimi N, Bayram Çatak F, Arslan E, Saghazadeh A, Rezaei N.

Int Immunopharmacol. 2022 Dec;113(Pt B):109445. doi: 10.1016/j.intimp.2022.109445. Epub 2022 Nov 18.

Alzheimer's Disease: Treatment Strategies and Their Limitations

Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A, Malaplate C, Yen FT, Arab-Tehrany E.

Int J Mol Sci. 2022 Nov 12;23(22):13954. doi: 10.3390/ijms232213954.

Research on the application effect of cognitive stimulation therapy in patients with Alzheimer's disease based on expert consultation and semistructured interviews

Shuzhen L, Hongyan G, Wei W, Ruiying W, Mulud ZA.

J Popul Ther Clin Pharmacol. 2022 Nov 24;29(4):e97-e106. doi: 10.47750/jptcp.2022.991. eCollection 2022.

Efficacy and safety of blood derivatives therapy in Alzheimer's disease: a systematic review and meta-analysis

Fei Z, Pan B, Pei R, Chen Z, Du X, Cao H, Li C.

Syst Rev. 2022 Nov 29;11(1):256. doi: 10.1186/s13643-022-02115-y.

Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease

Bateman RJ, Cummings J, Schobel S, Salloway S, Vellas B, Boada M, Black SE, Blennow K, Fontoura P, Klein G, Assunção SS, Smith J, Doody RS.

Alzheimers Res Ther. 2022 Nov 29;14(1):178. doi: 10.1186/s13195-022-01110-8.

Benefit and safety of antibiotics for Alzheimer's disease: Protocol for a systematic review and meta-analysis

Gao L, Shuai Y, Wen L, Zhang H, Zhang Y, Zhang X.

Medicine (Baltimore). 2022 Nov 25;101(47):e31637. doi: 10.1097/MD.0000000000031637.

Gamma frequency sensory stimulation in mild probable Alzheimer's dementia patients: Results of feasibility and pilot studies

Chan D, Suk HJ, Jackson BL, Milman NP, Stark D, Klerman EB, Kitchener E, Fernandez Avalos VS, de Weck G, Banerjee A, Beach SD, Blanchard J, Stearns C, Boes AD, Uitermarkt B, Gander P, Howard M 3rd, Sternberg EJ, Nieto-Castanon A, Anteraper S, Whitfield-Gabrieli S, Brown EN, Boyden ES, Dickerson BC, Tsai LH.

PLoS One. 2022 Dec 1;17(12):e0278412. doi: 10.1371/journal.pone.0278412. eCollection 2022.

The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer's disease

Du H, Meng X, Yao Y, Xu J.

Front Endocrinol (Lausanne). 2022 Nov 17;13:1033479. doi: 10.3389/fendo.2022.1033479. eCollection 2022.

Research Progress of Targeting Neuro-Immune Inflammation in the Treatment of Alzheimer's Disease

Chen H, Deng C, Meng Z, Meng S.

Front Biosci (Landmark Ed). 2022 Nov 25;27(11):312. doi: 10.31083/j.fbl2711312.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias